Articles
From open source to open science

From open source to open science

Is open science the new open source? Kevin Lustig shares his thoughts on how pharma can best use open science to increase open access to scientific data, as well as to increase innovation. Open science is the new open source. Amateur scientists are building community labs, the public is clamoring for greater...

Articles
Access to information changes everything, including the nature of the physician-patient relationship

Access to information changes everything, including the natu...

Bunny Ellerin addresses the changing nature of the physician-patient relationship and how it has evolved with increased access to health information. I remember the first time I fired a doctor. It was 2003, and I was pregnant. There were myriad issues I wanted to discuss with the...

Articles
Device ad-vice: three tips for positioning medical device brands

Device ad-vice: three tips for positioning medical device br...

Some hot tips on positioning medical device brands from HCB Health’s Amy Smith in the latest of the agency's ‘Device ad-vice’ series. Doctors are trained to make decisions objectively: evaluate the data, compare the alternatives, weigh the risks. But the process isn’t...

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. ESMO26: Tango sees 82% ORR with combo in pancreatic cancer
  2. Roche offers $15bn for strategic-level deal with Hansoh
  3. ESMO26: Moderna, MSD reveal cancer jab data early after leak
  4. Clinical trial setup times fall sharply in UK
  5. Despite US policy changes, drug prices stay stubbornly high

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more